A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism

NCT06881992 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

16

Enrollment

OTHER

Sponsor class

Conditions

Tumor Hyperinsulinism (Tumor HI)

Interventions

DRUG: Ersodetug

Sponsor

Rezolute